Neuropeptide Y is a minor autoantigen in newly diagnosed type 1 diabetes patients

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 16, Iss. 8, 2015-12 ,pp. : 621-628

John Wiley & Sons Inc

Access to resources Recommend Favorite

Type 1 diabetes mellitus and associated risk factors in patients with or without CHD: a case–control study

By  

Cardiology in the Young, Vol. 27, Iss. 9, 2017-05 ,pp. : 1670-1677

Cambridge University Press

Access to resources Recommend Favorite

Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case–control study in UK general practice

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 2, 2015-02 ,pp. : 205-213

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non‐autoimmune (type 2) diabetes

By Bolinder J.   Fernlund P.   Borg H.   Arnqvist H. J.   Björk E.   Blohmé G.   Eriksson J. W.   Nyström L.   Östman J.   Sundkvist G.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 65, Iss. 7, 2005-11 ,pp. : 585-594

Informa Healthcare

Access to resources Recommend Favorite

Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case–control study

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 1399-543X, Iss. 7, 2015-11 ,pp. : 546-553

John Wiley & Sons Inc

Access to resources Recommend Favorite